Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
94 Cards in this Set
- Front
- Back
A substance produced by a microorganism that suppresses the growth of other microorganisms
|
Antibiotic
|
|
Chemotherapeutic Drugs
|
Antimicrobial drugs
Antiparasitic drugs Antineoplastic drugs |
|
Antimicrobial drugs can be subclassified into the following:
|
Antibacterial
Antifungal Antiviral |
|
Any chemical used in the treatment, relief, or prophylaxis of a disease
|
Chemotherapeutic drug
|
|
Use of a drug to prevent imminent infection of a person at risk
|
Prophylaxis
|
|
Refers to the range of microorganisms that an antimicrobial agent can kill or inhibit
|
Spectrum of activity
|
|
Narrow spectrum agent or activity
|
Antimicrobials effective against a limited array of microbial types. Targets a specific cell component found only in certain microbes
ex. drug effective mainly against gram-positive bacteria |
|
Broad spectrum agent or activity
|
Antimicrobials effective against a wide variety of microbial types. Targets cell components common to most pathoges
ex. drug effective against both gram-positive and gram-negative |
|
Antimicrobial activity of a drug can be generally characterized in three ways:
|
-bactericidal versus bacteriostatic effect
-may have a concentration-dependent or time-dependent killing effect -its spectrum of activity against different microbes |
|
These antibiotics inhibit/stop the growth and reproduction of bacteria but do not kill them
|
Bacteriostatic agents
|
|
Works with the immune system to remove microorganisms from the body
|
Bacteriostatic agents
|
|
T/F: Most bacteriostatic agents are protein synthesis inhibitors
|
True
|
|
Tetracycline
|
Bacteriostatic
|
|
Macolides
|
Bacteriostatic
|
|
Kills bacteria
|
Bactericidal agents
|
|
Use of this type of drug is critical when the immune system is weak or depressed
|
Bactericidal agents
|
|
These types of drugs can have a concentration dependent or time dependent killing effect
|
Bactericidal
|
|
T/F: Drugs that target the cell wall are bacteriostatic
|
False
|
|
MIC
|
minimum inhibitory concentration; the lowest concentration of a drug that inhibits bacterial growth
|
|
Example of time-dependent, bactericidal agents
|
Beta-lactam antibiotics
|
|
T/F: Greater drug concentrations result in greater killing of bacteria with time-dependent bactericidal agents
|
False
|
|
Concentration-dependent killing
|
Bacterial kill increases with increasing levels of drug
|
|
Examples of concentration-dependent drugs
|
aminoglycosides and fluoroquinolones
|
|
T/F: Bacteriostatic drugs should be used in patients with impaired immune defense
|
False; bactericidal drugs should be used
|
|
Drug required for use in Endocarditis and Meningitis
|
Bactericidal drugs
|
|
Drugs required for use in infections in neutropenic cancer patients
|
Bactericidal drugs; b/c anti-cancer drugs suppress the immune system
|
|
To adversely affect one type of cell and spare normal human cells:
|
Selective toxicity
|
|
What does penicillin target?
|
bacterial cell wall
|
|
How are antimicrobials classified?
|
What they target or mechanism of action
|
|
Common target of agents that inhibit synthesis of bacterial cell walls:
|
peptidoglycan in bacterial cell wall
|
|
Beta-lactam antibiotics
|
inhibit synthesis of bacterial cell walls
|
|
Beta-lactam antibiotics
|
inhibit insertion of peptidoglycan into cell wall
|
|
largest and most widely prescribed antibiotic class
|
Beta-lactam antibiotics
|
|
Vancomycin
|
cell wall inhibitor
|
|
Bacitracin
|
cell wall inhibitor
|
|
Key to beta-lactam mechanism of action
|
beta-lactam ring
|
|
What does beta-lactam ring bind to?
|
penicillin binding proteins; key bacterial enzymes in cell wall synthesis
|
|
Penicillin
|
beta-lactam
|
|
cephalosporin
|
beta-lactam
|
|
monobactam
|
beta-lactam
|
|
carbapenems
|
beta-lactam
|
|
Enzyme that cleaves beta-lactam bond
|
beta-lactamase; breaks beta-lactam ring; drug is inactive
|
|
what determines spectrum of antibacterial activity?
|
R side chains
|
|
Enzyme that breaks beta-lactam bond in penicillin
|
penicillinase
|
|
Enzyme that breaks beta-lactam bond in cephalosporin
|
cephalosporinase
|
|
MRSA
|
methicillin-resistant Staphylococcus aureus
|
|
T/F: beta-lactam antibiotics work against MRSA
|
False
|
|
T/F: PBP is altered in MRSA
|
True; that's why beta-lactam drugs are ineffective because they can't dint to the pencillin binding protein
|
|
4 groups of beta-lactams
|
1) Natural penicillins
2) Cephalosporins 3) Carbapenems 4) Monobactams |
|
T/F: beta-lactams are bactericidal
|
True
|
|
T/F: beta-lactams are concentration-dependent killers
|
False; beta-lactams are time-dependent killers
|
|
penicillin G
|
natural penicillin
|
|
nafcillin
|
Penicillinase-resistant penicillin
|
|
amoxicillin
|
Extended-spectrum penicillins
|
|
ticarcillin
|
Antipseudomonal penicillins
|
|
Methicillin-like antibiotic
|
nafcillin
|
|
penicillin G
|
narrow spectrum antibiotic; gram-positive bacteria
|
|
Largest and most widely used class of antibiotics
|
Cephalosporins
|
|
First generation Cephalosporins
|
Cephalexin
|
|
Second generation Cephalosporins
|
Cefoxitin
|
|
Third generation Cephalosporins
|
Ceftriaxone
|
|
Fourth generation Cephalosporin
|
Cefepime
|
|
2nd, 3rd, and 4th generation cephalosporins:
|
increased activity against gram-negative, increased resistance to beta-lactamases, increased ability to cross BBB
|
|
Imipenem
|
Carbapenems
|
|
Aztreonam
|
Monobactams
|
|
Other cell wall inhibitors
|
Vancomycin and Bacitracin
|
|
Vancomycin
|
does not cross lipid membrane of gram-negative bacteria
|
|
Acquired antibiotic resistance to Vancomycin due to:
|
amino acid alterations in side chain peptidoglycan building blocks; drug binding site is mutated
|
|
Bacitracin
|
interferes with transport of peptidoglycan precursors across cytoplasmic membrane; cell wall synthesis is inhibited; toxicity limits use to topical applications
|
|
Polymyxin and daptomycin
|
act directly on the bacterial cell membrane; disrupt the integrity of the cell membrane; increase permeability leading to leakage of intracellular components
|
|
daptomycin
|
binds to bacterial membranes causing rapid depolarization and loss of membrane potential leading to cell death
|
|
polymyxin and daptomycin
|
bactericidal with concentration-dependent killing
|
|
Drugs that are generally bacteriostatic agents:
|
agents that inhibit bacterial protein synthesis; shutting down protein synthesis does not kill bacteria
|
|
Doxycycline
|
Tetracyclines
Inhibit protein synthesis |
|
Erythromycin
|
Macrolides
Inhibit protein synthesis |
|
Gentamycin
|
Aminoglycosides
Inhibit protein synthesis |
|
Drugs that irreversibly inhibit protein synthesis
|
Aminoglycosides
|
|
T/F: Drugs that inhibit protein synthesis are irreversible
|
False
|
|
Tetracycline resistance
|
Efflux pump and ribosome protection
|
|
Aminoglycoside resistance
|
microbial enzymes and aminoglycoside modifying enzymes
|
|
Macrolide resistance
|
Efflux pump and ribosome modification
|
|
Rifampin
|
Inhibition of RNA polymerase
Interferes with nucleic acid synthesis |
|
Fluoroquinolones
|
Inhibition of DNA replication
Interferes with nucleic acid synthesis |
|
Ciproflaxin
|
Inhibition of DNA replication
Interferes with nucleic acid synthesis |
|
T/F: Drugs that interfere with nucleic acid synthesis are bactericidal
|
True
|
|
Trimethoprim
|
Metabolic inhibitor
|
|
Sulfonamides
|
Metabolic inhibitor
|
|
Sulfamethoxazole
|
Metabolic inhibitor
|
|
Drugs that target the folic acid synthesis pathway:
|
Drugs that inhibit synthesis of essential metabolites
|
|
Cofactor needed for synthesizing the building blocks of DNA
|
Folic acid
|
|
Describes the atomic or molecular structure of drug
|
Chemical name
|
|
Official name of the drug
|
Generic name
|
|
Name that is public property
|
Generic name
|
|
Brand name
|
Trade name
|